MiniMed Executive and Leadership Team

Chad Spooner, the Chief Financial Officer at MiniMed, manages all fiscal planning, capital allocation, and financial reporting processes. Overseeing the economic health of the organization, the Chief Financial Officer ensures that resources remain focused on the research and development of insulin delivery systems. This leadership role involves coordinating with the Board to maintain long-term financial stability while supporting aggressive growth in the medical device sector. Chad Spooner drives operational efficiency by implementing rigorous cost-management protocols across all manufacturing and administrative departments. By analyzing market trends and revenue streams, the Chief Financial Officer provides the strategic foresight necessary to navigate the complexities of the healthcare industry. Spooner maintains a disciplined approach to investment, ensuring that every dollar spent advances the core mission of making life easier for patients living with diabetes, thereby sustaining the company's market leadership.

Kate Cronin, the Chief Marketing Officer at MiniMed, directs all global brand positioning and patient engagement strategies. By translating complex insulin delivery technology into accessible narratives, the Chief Marketing Officer ensures that the MiniMed mission resonates with diverse patient populations across North American and international markets. This leadership role involves architecting multi-channel campaigns that highlight how medical devices allow diabetes to fade into the background of daily life. Kate Cronin maintains close alignment with product development teams to ensure marketing communications accurately reflect the technical capabilities of the insulin delivery systems. Through data-driven insights, the Chief Marketing Officer optimizes outreach efforts to increase market penetration and brand loyalty. Ultimately, Cronin secures a stronger competitive position by fostering deep trust between the company and the global diabetes community, ensuring that every patient understands the value of the provided medical solutions.

Matthew Skattum, the Chief Information Officer, Integrated Supply Operations, Quality & Innovation at MiniMed, architects the digital infrastructure and supply chain logistics required for high-precision medical manufacturing. Overseeing the integration of quality control systems with global distribution networks, the Chief Information Officer, Integrated Supply Operations, Quality & Innovation ensures that every insulin delivery device meets stringent regulatory standards. This leadership role involves driving technological innovation to streamline production cycles and reduce lead times for patients. Matthew Skattum coordinates with engineering teams to implement advanced data analytics that improve product reliability and manufacturing output. By optimizing the end-to-end supply chain, the Chief Information Officer, Integrated Supply Operations, Quality & Innovation supports the company's ability to scale operations across diverse geographic regions. Skattum maintains a focus on operational excellence, ensuring that the technological backbone of the company remains robust, secure, and capable of supporting future product advancements.

Gill Chandrasena, the Senior Vice President, Chief Human Resources Officer at MiniMed, directs all talent acquisition, organizational development, and corporate culture initiatives. Overseeing the recruitment of top-tier engineering and medical talent, the Senior Vice President, Chief Human Resources Officer ensures that the workforce remains aligned with the company's mission to lift the burden of diabetes. This leadership role involves designing comprehensive training programs that foster innovation and cross-functional collaboration among diverse teams. Gill Chandrasena drives performance management strategies that reward excellence and support the professional growth of every employee. By cultivating an inclusive and high-performance environment, the Senior Vice President, Chief Human Resources Officer strengthens the internal capabilities required to maintain a competitive edge in the medical device industry. Chandrasena maintains a focus on employee engagement, ensuring that the organizational structure supports the rapid pace of technological development and the overall strategic goals of the company.

Ali Dianaty, the Executive VP & Chief Product & Technology Officer at MiniMed, architects the next generation of insulin delivery systems and digital health platforms. Overseeing the entire product lifecycle from initial research to final market launch, the Executive VP & Chief Product & Technology Officer ensures that all technology directly addresses the daily challenges faced by patients. This leadership role involves directing large-scale engineering teams to integrate advanced sensors and software into user-friendly medical devices. Ali Dianaty drives the strategic roadmap for product innovation, ensuring that the company remains at the forefront of the diabetes technology market. By collaborating with clinical and regulatory experts, the Executive VP & Chief Product & Technology Officer guarantees that all new developments meet the highest safety and efficacy standards. Dianaty maintains a focus on user-centric design, ensuring that every technological advancement makes life feel lighter, easier, and more possible for patients worldwide.